Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API

ELAN
Elanco Animal Health Incorporated Common Stock
stock NYSE

At Close
Aug 7, 2026 3:59:58 PM EDT
22.10USD-8.678%(-2.10)22,073,879
0.00Bid   0.00Ask   0.00Spread
Pre-market
Aug 6, 2026 9:27:30 AM EDT
25.56USD+5.620%(+1.36)0
After-hours
Aug 7, 2026 4:59:30 PM EDT
22.49USD+1.765%(+0.39)91,431
OverviewOption ChainMax PainOptionsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 21, 2022
06:58AM EST  Elanco's Long-Acting Transdermal Buprenorphine for Cats Gains FDA Approval   Benzinga
05:21AM EST  Elanco's ZORBIUM Buprenorphine Transdermal Solution Gains U.S. Approval   Benzinga
Jan 20, 2022
04:30PM EST  Elanco's ZORBIUM(tm) (Buprenorphine Transdermal Solution) - the First Long-Acting Transdermal Buprenorphine for Cats - Gains U.S. Approval   Business Wire
Jan 4, 2022
04:30PM EST  Elanco to Participate in the 40th Annual J.P. Morgan Healthcare Conference   Business Wire
Nov 30, 2021
04:52PM EST  Elanco To Lay Off 20% Senior Management In Organizational Restructure   Benzinga
07:31AM EST  Elanco Animal Health Incorporated (ELAN) announced proposed structural changes to simplify the organization. The restructuring will eliminate approximately 380 positions around the world, including reducing the company's senior management by approximately 20%.   RTTNews
07:07AM EST  Elanco Animal Health To Eliminate About 380 Positions Globally   RTTNews
07:00AM EST  Elanco Announces Changes to Simplify Organizational Structure, Drive Profitable Growth and Focus Investments on Growth and Innovation Opportunities   Business Wire
Nov 18, 2021
10:19AM EST  Benzinga's Top Ratings Upgrades, Downgrades For November 18, 2021   Benzinga
09:37AM EST  Morgan Stanley Initiates Coverage On Elanco Animal Health with Overweight Rating, Announces Price Target of $40   Benzinga
Nov 5, 2021
09:43AM EDT  The Daily Biotech Pulse: NRx's Zyesami Face Regulatory Rejection, Puma Slumps On Q3 Miss, Pfizer Has Good Tidings On Oral Antiviral COVID-19 Pill   Benzinga
09:37AM EDT  Elanco Animal Health Q3 Adj. EPS $0.19 Beats $0.16 Estimate, Sales $1.13B Beat $1.08B Estimate   Benzinga
09:37AM EDT  Elanco Animal Health Sees Q4 Sales $1.078B-$1.118B vs $1.12B Estimate, Adj. EPS $0.13-$0.19 vs $0.19 Estimate   Benzinga
09:36AM EDT  Earnings Scheduled For November 5, 2021   Benzinga
06:43AM EDT  Elanco Animal Health Q3 Loss/shr $0.21 Vs. Loss/shr $0.29 Last Year   RTTNews
06:30AM EDT  Elanco Animal Health Reports Third Quarter 2021 Results Exceeding Revenue Guidance; Raising Full Year 2021 Revenue Guidance   Business Wire
Nov 4, 2021
10:27AM EDT  Earnings Preview For Elanco Animal Health   Benzinga
Oct 31, 2021
02:24PM EDT  The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline   Benzinga
Oct 28, 2021
10:48AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For October 28, 2021   Benzinga
06:10AM EDT  Stifel Downgrades Elanco Animal Health to Hold, Lowers Price Target to $34   Benzinga
Oct 18, 2021
04:15PM EDT  Elanco Animal Health Selected for 2021 FORTUNE's Change the World List   Business Wire
Oct 7, 2021
08:30AM EDT  Elanco Confirms Date and Conference Call for Third Quarter 2021 Financial Results Announcement   Business Wire
Oct 5, 2021
06:37AM EDT  Elanco Animal Health Names Ellen De Brabander New EVP Of Innovation And Regulatory Affairs   RTTNews
06:32AM EDT  Elanco Says Continues To Expect $600M-$700M In Innovation Revenue By 2025   Benzinga
06:30AM EDT  Elanco Announces New Innovation Leader, Additional Strategic Move to Increase Focus on High-Value, Late-Stage Pet Health Pipeline Progress   Business Wire
Sep 29, 2021
08:30AM EDT  Climate-Neutral Beef, Dairy Could Reach Store Shelves by 2050, According to New Research   Business Wire
Aug 30, 2021
06:48AM EDT  Elanco Animal Health Closes Acquisition Of Kindred Biosciences   RTTNews
06:45AM EDT  Elanco Closes Acquisition of Kindred Biosciences   Business Wire
Aug 25, 2021
08:30AM EDT  Elanco to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference   Business Wire
Aug 18, 2021
03:58PM EDT  Hagens Berman urges Elanco Animal Health, Inc. (NYSE: ELAN) investors with significant losses to submit your losses now. The firm is investigating possible securities law violations and certain investors may have valuable claims.   GlobeNewswire Inc
Aug 14, 2021
12:33PM EDT  The Past Week's Notable Insider Buys: ConocoPhillips, Cricut, Energy Transfer And More   Benzinga
Aug 11, 2021
02:01AM EDT  TriRx Hosted State and Community Leaders to Celebrate Acquisition of Shawnee,   PR Newswire
Aug 10, 2021
08:00PM EDT  ELANCO ALERT: Bragar Eagel & Squire, P.C. is Investigating Elanco Animal Health Incorporated on Behalf of Elanco Stockholders and Encourages Investors to Contact the Firm   Business Wire
09:36AM EDT  Investors to Contact Firm's Attorneys Now, Firm Investigating Possible Securities Law Violations   PR Newswire
08:16AM EDT  (ELAN) Elanco Animal Health Alert: Did You Lose Money on Your Investment?   PR Newswire
Aug 9, 2021
03:24PM EDT  Hagens Berman urges Elanco Animal Health, Inc. (NYSE: ELAN) investors with significant losses to submit your losses now. The firm is investigating possible securities law violations and certain investors may have valuable claims.   GlobeNewswire Inc
11:07AM EDT  The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight   Benzinga
10:19AM EDT  Shares of Elanco Animal Health Incorporated (ELAN) are falling more than 17% Monday morning following second quarter results.   RTTNews
07:03AM EDT  Elanco Animal Health: Q2 Earnings Insights   Benzinga
06:37AM EDT  Elanco Animal Health Posts Q2 Loss Per Share Of $0.43; Adj EPS Of $0.28   RTTNews
06:34AM EDT  Elanco Animal Health Sees Q3 Adj. EPS $0.15-$0.19 vs $0.20 Est., Sales $1.075B-$1.10B vs $1.09B Est.   Benzinga
06:33AM EDT  Elanco Animal Health Revises FY21 Adj. EPS Guidance From $1.00-$1.06 To $0.97-$1.03 vs $1.04 Est., Revises Sales Guidance From $4.67B-$4.71B To $4.68B-$4.73B vs $4.71B Est.   Benzinga
06:31AM EDT  Elanco Animal Health Q2 Adj. EPS $0.28 Beats $0.26 Estimate, Sales $1.28B Beat $1.23B Estimate   Benzinga
06:30AM EDT  Elanco Animal Health Reports Second Quarter 2021 Results   Business Wire
04:11AM EDT  Earnings Scheduled For August 9, 2021   Benzinga
Aug 8, 2021
10:11AM EDT  The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight   Benzinga
Aug 2, 2021
02:03AM EDT  TriRx Closes Acquisition Of Elanco Animal Health Facility In Shawnee, Kansas   RTTNews
02:01AM EDT  TriRx Completes Acquisition of Elanco Animal Health Facility in Shawnee, Kansas   PR Newswire
Jul 19, 2021
08:35AM EDT  Elanco Animal Health Says Co's TANOVEA Receives Full FDA Approval As First Treatment For Lymphoma In Dogs; Co Says Acquires Product From VetDC   Benzinga
Jul 12, 2021
08:30AM EDT  Elanco Confirms Date and Conference Call for Second Quarter 2021 Financial Results Announcement   Business Wire
Jun 30, 2021
04:31PM EDT  Elanco Foundation Announces Partnership with the JBS Fund   Benzinga
Jun 23, 2021
12:01PM EDT  SHAREHOLDER ALERT: WeissLaw LLP Reminds KIN, FMBI, SLCT, and CNST   GlobeNewswire Inc
Jun 16, 2021
12:14PM EDT  SHAREHOLDER ALERT: WeissLaw LLP Investigates Kindred Biosciences, Inc.   GlobeNewswire Inc
12:03PM EDT  Mid-Day Market Update: Dow Falls 40 Points; Aprea Therapeutics Shares Surge   Benzinga
10:17AM EDT  Mid-Morning Market Update: Markets Mixed; Elanco Animal Health To Acquire Kindred Biosciences   Benzinga
07:07AM EDT  Elanco Animal Health Inc. (ELAN) and veterinary biopharmaceutical company Kindred Biosciences, Inc. (KIN) announced Wednesday they have entered into a definitive agreement for Elanco to acquire Kindred for $9.25 per share, or approximately $440 million.   RTTNews
06:51AM EDT  Kindred Biosciences Stock Jumps On $440M Elanco Animal Buyout Deal   Benzinga
06:33AM EDT  Elanco Animal Health To Acquire Kindred Biosciences At $9.25/Shr   RTTNews
06:32AM EDT  Elanco Reaffirms Q2 Sales Guidance Of $1.225B-$1.255B vs $1.1B Est. And FY21 Sales Guidance Of $4.67B-$4.71B vs $4.7B Est.   Benzinga
06:31AM EDT  Elanco Announces Agreement To Acquire Kindred Biosciences For $9.25/Share   Benzinga
06:30AM EDT  Elanco Announces Agreement to Acquire Kindred Biosciences   PR Newswire
Jun 15, 2021
11:00AM EDT  Elanco Animal Health's Debt Overview   Benzinga
10:53AM EDT  Shares of pharmaceutical company Elanco Animal Health Inc.(ELAN) are up 6 percent on Tuesday's trading as the company announced an agreement with TriRx Pharmaceutical Services Inc., for the sale of Elanco's two facilities at Shawnee, Kansas and Speke, UK.   RTTNews
10:37AM EDT  TriRx Earlier Announces Co. Entered Into An Agreement for the Acquisition of Elanco Animal Health Facilities in Shawnee, Kansas and Speke, United Kingdom   Benzinga
03:06AM EDT  TriRx Pharmaceutical Services Inc. said that it agreed to acquire two facilities from Elanco Animal Health Inc. (ELAN).   RTTNews
02:57AM EDT  TriRx Announces Agreement To Acquire Two Facilities From Elanco Animal Health   RTTNews
02:01AM EDT  TriRx Enters Agreement for the Acquisition of Elanco Animal Health Facilities   PR Newswire
Jun 10, 2021
06:38AM EDT  Elanco Animal Health Releases Environmental, Social And Governance Summary   RTTNews
06:30AM EDT  Elanco Releases Environmental, Social and Governance (ESG) Summary   Business Wire
Jun 9, 2021
01:33PM EDT  Elanco To Exit Three Manufacturing Sites To Streamline Footprint   Benzinga
09:39AM EDT  Elanco Animal Health Inc. (ELAN) announced exit of three manufacturing sites. TriRx Pharmaceuticals will purchase the sites in Shawnee, Kan. and Speke, UK, including planned transfer of 600 employees.   RTTNews
09:20AM EDT  Elanco To Sell Manufacturing Sites In In Shawnee, Kan., And Speke, U.K.   RTTNews
09:15AM EDT  Elanco Announces Exit of Three Manufacturing Sites, Streamlining Footprint   Business Wire
Jun 4, 2021
08:00AM EDT  Elanco Announces Addition of Marcela A. Kirberger as General Counsel and Corporate Secretary   Business Wire
Jun 2, 2021
08:38AM EDT  Kindred Biosciences Announces Results From Pivotal Efficacy Study Of Parvovirus Monoclonal Antibody; Results Showed 100% Survival In Treated Group vs 43% Survival In Placebo Group   Benzinga
08:38AM EDT  Kindred Biosciences Announced Positive Results From Pivotal Efficacy Study Of KIND-030 In Dogs Infected By Parvovirus   RTTNews
08:38AM EDT  Parvovirus Monoclonal Antibody for the Prevention of Deaths in Dogs Infected by Parvovirus   PR Newswire
May 25, 2021
07:18AM EDT  EVAH Corp. Inks Four Contracts With Elanco Animal Health To Acquire And Develop Technologies In Animal Health   RTTNews
07:05AM EDT  EVAH Signs Four Contracts With Elanco; Terms Not Disclosed   Benzinga
May 21, 2021
07:26AM EDT  The Daily Biotech Pulse: Moderna's Vaccine Authorized In Japan, Neovasc's Adverse Ruling In Germany, Metacrine Rallies On Insider Buying   Benzinga
May 20, 2021
05:00PM EDT  Elanco to Participate in Upcoming Investor Conferences   Business Wire
May 19, 2021
07:30AM EDT  The Daily Biotech Pulse: Iovance To Delay Regulatory Filing For Cancer Therapy, Departures At Passage Bio, Positive Readout For Silence Therapeutics   Benzinga
May 18, 2021
07:44AM EDT  The Daily Biotech Pulse: Spero Secures NIAID Funding, GlaxoSmithKline Releases COVID-19 Data, BioNTech Gets New CFO   Benzinga
May 15, 2021
01:39PM EDT  Last Week's Notable Insider Buys: Activision, Avis Budget, Energy Transfer And More   Benzinga
May 14, 2021
04:29PM EDT  Starboard Value 13F Filing Shows New Stakes In eHealth, Elanco, CC Neuberger Principal Holdings II, Khosla Ventures Acquisition Co III And TWC Tech Holdings II Corp   Benzinga
04:15PM EDT  Starboard Value Takes Share Stake Of 7.83M Shares Of Common Stock In Elanco Animal Health   Benzinga
May 11, 2021
11:50AM EDT  Gabelli & Co. Upgrades Elanco Animal Health to Buy   Benzinga
10:07AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For May 11, 2021   Benzinga
08:00AM EDT  Elanco Launches Product for U.S. Poultry Producers, Providing a Flexible Option for Cocci Control   Business Wire
07:20AM EDT  Barclays Upgrades Elanco Animal Health to Equal-Weight, Raises Price Target to $29   Benzinga
May 7, 2021
11:47AM EDT  Elanco Shares Rise After Q1 Earnings Exceed Expectations, Raises FY21 Outlook   Benzinga
07:55AM EDT  Elanco Animal Health Inc. (ELAN) raised and tightened its full year 2021 guidance for revenue, and adjusted earnings per share, compared to the prior guidance.   RTTNews
07:40AM EDT  The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs   Benzinga
06:35AM EDT  Elanco Sees Q2 Sales $1.225B-$1.255B vs $1.16B Estimate, Adj. EPS $0.22-$0.27 vs $0.25 Est.   Benzinga
06:34AM EDT  Elanco Animal Health Q1 Adj. EPS $0.37 Beats $0.23 Estimate, Sales $1.24B Beat $1.16B Estimate   Benzinga
06:33AM EDT  Elanco Animal Health Q1 Loss/Shr $0.12, Same As Last Year   RTTNews
06:32AM EDT  Elanco Animal Health Reports First Quarter 2021 Results   Business Wire
04:12AM EDT  Earnings Scheduled For May 7, 2021   Benzinga
May 6, 2021
10:10AM EDT  Earnings Preview for Elanco Animal Health   Benzinga
May 4, 2021
08:17AM EDT  Elanco Animal Health Introduces Credelio CAT (lotilaner), First Oral Flea And Tick Product For Cats   Benzinga
08:00AM EDT  Elanco Animal Health Introduces First Oral Flea and Tick Product for Cats, Credelio(r) CAT (lotilaner)   Business Wire
Apr 28, 2021
08:36AM EDT  Kindred Biosciences Announces Acceptance Of Parvovirus Antibody Prophylaxis Study Data And Approval Of Efficacy Indication   Benzinga
08:32AM EDT  Kindred Biosciences Announces Acceptance of Parvovirus Antibody Prophylaxis   PR Newswire
Apr 21, 2021
04:42PM EDT  Elanco Animal Health and Ducks Unlimited Announce Partnership to Advance Beef Industry Environmental Stewardship Efforts   Benzinga
Apr 15, 2021
10:03AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For April 15, 2021   Benzinga
06:44AM EDT  Stifel Initiates Coverage On Elanco Animal Health with Buy Rating, Announces Price Target of $37   Benzinga
Apr 7, 2021
08:30AM EDT  Elanco Confirms Date and Conference Call for First Quarter 2021 Financial Results Announcement   Business Wire
Mar 22, 2021
10:43AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For March 22, 2021   Benzinga
09:13AM EDT  Gabelli & Co. Downgrades Elanco Animal Health to Hold, Announces $32 Price Target   Benzinga
Mar 19, 2021
06:31AM EDT  Elanco Reiterates Support Of Safety Data Of Co.'s Seresto Generated For Its Registration, Monitored Via Post-Marketing Surveillance   Benzinga
06:30AM EDT  Elanco Stands Behind Seresto and its Safety Profile   Business Wire
05:05AM EDT  Morris Animal Foundation Partners With Elanco Animal Health   RTTNews
05:01AM EDT  Morris Animal Foundation Partners with Elanco to Improve Understanding of   PR Newswire
Mar 16, 2021
08:17AM EDT  The Daily Biotech Pulse: Fulgent Nabs CDC Contract, Enzo Rallies, Solid Biosciences Releases Gene Therapy Data, Moderna Begins Pediatric Vaccine Study   Benzinga
Mar 3, 2021
02:11PM EST  'Starboard Takes Elanco Stake, Nominates Three to Its Board' -Wall Street Journal   Benzinga
Feb 26, 2021
10:04AM EST  Benzinga's Top Ratings Upgrades, Downgrades For February 26, 2021   Benzinga
07:46AM EST  Credit Suisse Upgrades Elanco Animal Health to Outperform, Raises Price Target to $38   Benzinga
Feb 25, 2021
01:37PM EST  Kindred Biosciences Submits Efficacy Data For KIND-030 As Prophylactic Option In US   Benzinga
07:39AM EST  A Look Into Elanco Animal Health's Debt   Benzinga
Feb 24, 2021
07:13AM EST  Elanco Animal Health Incorporated (ELAN) reported fourth-quarter net loss of $322.8 million and $0.66 per share compared with $9.5 million or $0.03 per loss per share in the same quarter a year ago. The company also raised its annual outlook   RTTNews
07:06AM EST  Recap: Elanco Animal Health Q4 Earnings   Benzinga
06:38AM EST  Elanco Animal Health Sees Q1 Adj. EPS $0.20-$0.25 vs $0.22 Est.   Benzinga
06:38AM EST  Elanco Animal Health Q4 Adj. EPS $0.12 Beats $0.09 Estimate, Sales $1.14B Beat $1.06B Estimate   Benzinga
06:34AM EST  Elanco Animal Health Q4 Loss/Shr $0.66 Vs Loss $0.03 Last Year   RTTNews
06:30AM EST  Elanco Animal Health Reports Fourth Quarter and Full Year 2020 Results   Business Wire
03:35AM EST  Earnings Scheduled For February 24, 2021   Benzinga
Feb 22, 2021
08:00AM EST  Elanco General Counsel Michael-Bryant Hicks to Depart After Successful Company Stand-Up and Acquisition Completion   Business Wire
Feb 19, 2021
10:08AM EST  Elanco Animal Health shares were trading higher after the company said Increxxa approved by the FDA for the U.S. cattle and swine producers.   Benzinga
08:42AM EST  Elanco Says Increxxa Approved By FDA For U.S. Cattle And Swine Producers, Veterinarians   Benzinga
08:06AM EST  Elanco Announces Four Important Innovation Milestones, including Two Product Approvals   RTTNews
08:00AM EST  Elanco Achieves Important Innovation Milestones, Momentum to Start 2021   Business Wire
Feb 18, 2021
08:30AM EST  Elanco to Participate in the Cowen 41st Annual Health Care Conference   Business Wire
Feb 12, 2021
08:30AM EST  Elanco to Participate in the BofA Securities Animal Health Virtual Summit   Business Wire
Jan 27, 2021
08:30AM EST  Elanco Confirms Date and Conference Call for Fourth Quarter 2020 Financial Results Announcement   Business Wire
Jan 26, 2021
08:45AM EST  Elanco Announces Restructuring; To Eliminate Approx. 350   RTTNews
08:35AM EST  Elanco Plans Restructuring; To Eliminate 350 Positions   RTTNews
08:05AM EST  Elanco Animal Health Raises FY21 Adj. EPS Guidance From $0.83-$0.95 To $0.86-$0.96 vs $0.89 Est.   Benzinga
08:04AM EST  Elanco Animal Health Announces Proposed Restructuring Actions Expected To Generate $20M-$24M In Cost Savings In 2021   Benzinga
08:00AM EST  Elanco Announces Next Wave of Restructuring to Drive Operational Efficiencies Post Bayer Acquisition   Business Wire
Jan 19, 2021
08:03AM EST  Dr. Marijn Dekkers Named Chairman of AgBiome Board of Directors   PR Newswire
Jan 11, 2021
07:32AM EST  Elanco Animal Health Inc. (ELAN) announced Monday that executive vice president of Transformation and Technology, Sarena Lin, will take a role outside of the company at the end of January.   RTTNews
07:18AM EST  Elanco Animal Health Commences Next Phase Of Integration Post-Bayer Animal Health Acquisition   RTTNews
07:00AM EST  Elanco Begins Next Phase of Integration Post-Bayer Animal Health Acquisition; Executive Committee Member Sarena Lin to Depart   Business Wire
Dec 29, 2020
05:44AM EST  Elanco Tiergesundheit AG Issued U.S. Patent 10,874,618 'Compositions for treatment of heart failure in dogs'   Benzinga
Dec 22, 2020
08:30AM EST  Elanco to Participate in the 39th Annual J.P. Morgan Healthcare Conference   Business Wire
Dec 15, 2020
08:55AM EST  Elanco Animal Health Inc. (ELAN) said it raised its fourth-quarter revenue guidance. It provides 2020 financial targets and 2021 guidance, and is outlining a comprehensive roadmap to long-term margin and net leverage target.   RTTNews
08:09AM EST  Elanco Animal Health Now Sees Q4 Adjusted EPS Of $0.06-$0.12, Total Revenue $1.04 Bln-$1.07 Bln   RTTNews
08:09AM EST  Elanco Sees FY20 Sales $4.37B-$4.4B vs $3.18B Estimate, Adj. EBITDA $780M-$800M   Benzinga
08:08AM EST  Elanco Sees FY21 Sales $4.52B-$4.6B vs $4.52B Estimate, Adj. EPS $0.83-$0.95 vs $1.04 Est.   Benzinga
08:07AM EST  Elanco Animal Health Raises, Narrows Q4 Sales Guidance To $1.04B-$1.07B vs $1.05B Estimate, Adj. EPS $0.06-$0.12 vs $0.12 Estimate   Benzinga
08:00AM EST  Elanco Animal Health Hosts Investor Day, Demonstrating Inflection Point Toward Accelerated Value Creation   Business Wire
Dec 14, 2020
04:05PM EST  Elanco Appoints New Independent Directors to the Board and Expands Innovation and Operational Oversight   Business Wire
Dec 11, 2020
08:13AM EST  Elanco Reaches Deal With Kindred To Acquire Global Rights   RTTNews
08:04AM EST  Elanco Animal Health Enters Agreement With Kindred Biosciences To Acquire Exclusive Global Rights To KIND-030   RTTNews
08:02AM EST  Elanco Reports Deal with KindredBio For Canine Parvovirus Therapy To Market; Global License Includes $500K Upfront Payment, Added Milestones   Benzinga
08:01AM EST  Kindred Biosciences Announces Agreement Granting Elanco Exclusive Global Rights   PR Newswire
08:00AM EST  Elanco Announces Agreement with KindredBio to Bring First-of-its-Kind Canine Parvovirus Therapy to Market   Business Wire
Dec 4, 2020
07:36AM EST  Elanco Animal Health Chooses Indiana As Home For Global HQ And Future Footprint Consolidation   RTTNews
07:30AM EST  Elanco Animal Health Selects Indiana as Home for Global HQ and Future Footprint Consolidation   Business Wire
Dec 3, 2020
05:01PM EST  Elanco Animal Health Reports Holder Bayer Aktiengesellschaft Sells 54.5M Shares At Average Price $29.84/Share   Benzinga
Dec 1, 2020
08:30AM EST  Elanco to Host Virtual Investor Day, Provide 2021 Guidance   Business Wire
04:34AM EST  Bayer Sells $1.6B Stake In Elanco Animal Health   Benzinga
03:27AM EST  Bayer (BAYZF.PK, BAYRY.PK, BYR.L) said that it has placed 54.5 million shares of Elanco Animal Health at a price of $30.25 per share.   RTTNews
Nov 30, 2020
10:35PM EST  Elanco Announces Pricing Of Public Offering Of 54.5 Mln Common Stock By Selling Shareholder At $30.25/Shr   RTTNews
10:33PM EST  Elanco Animal Health Inc (ELAN) announced the pricing of public offering of 54.50 million shares of its common stock held by Bayer World Investments B.V, an affiliate of Bayer AG, at $30.25 per share.   RTTNews
10:00PM EST  Elanco Announces Pricing of Public Offering of Common Stock by Selling Shareholder   Business Wire
09:42AM EST  Elanco Animal Health shares were trading lower after the company announced a 54.5 million share common stock offering by its shareholder Bayer World Investments.   Benzinga
07:11AM EST  Elanco Launches Public Offering Of 54.50 Mln Shares Held By Bayer   RTTNews
07:05AM EST  Elanco Animal Health Announces 54.5M Share Offering by Shareholder Bayer World Investments   Benzinga
07:00AM EST  Elanco Announces Public Offering of Common Stock by Selling Shareholder   Business Wire
Nov 24, 2020
08:35AM EST  Morgan Stanley Maintains Overweight on Elanco Animal Health, Raises Price Target to $41   Benzinga
Nov 19, 2020
08:30AM EST  Elanco to Participate in the 3rd Annual Evercore ISI Virtual HealthCONx Conference   Business Wire
Nov 17, 2020
07:28AM EST  Citigroup Maintains Buy on Elanco Animal Health, Raises Price Target to $35   Benzinga
Nov 6, 2020
07:47AM EST  The Daily Biotech Pulse: Novartis Drug Flunks COVID-19 Study, Molecular Templates' Blood Cancer Study Placed On Partial Hold   Benzinga
07:46AM EST  Elanco Animal Health: Q3 Earnings Insights   Benzinga
06:59AM EST  Elanco Animal Health Inc. (ELAN) reported Friday that its net loss for the third quarter was $135.0 million or $0.29 per share, compared to net income of $10.0 million or $0.03 per share in the year-ago period.   RTTNews
06:37AM EST  Elanco Animal Health Q3 Loss/Shr $0.29 Vs EPS $0.03 Last Year   RTTNews
06:32AM EST  Elanco Animal Health Reports Third Quarter 2020 Results   Business Wire
06:30AM EST  Elanco Animal Health Q3 Adj. EPS $0.13 Beats $0.12 Estimate, Sales $889.60M Miss $909.34M Estimate   Benzinga
03:33AM EST  Earnings Scheduled For November 6, 2020   Benzinga
Nov 1, 2020
09:40AM EST  The Week Ahead In Biotech (Nov. 1-7): Adcom Test For Biogen's Aducanumab, Alzheimer's Conference, SMID-cap Earnings   Benzinga
Oct 29, 2020
08:00AM EDT  Elanco to Participate in the Credit Suisse 29th Annual Virtual Healthcare Conference   Business Wire
Oct 28, 2020
08:08AM EDT  Elanco Announces FDA Approves Elura, A New Prescription Medication To Manage Weight Loss In Cats With Chronic Kidney Disease   Benzinga
08:06AM EDT  Elanco's Elura(tm) (capromorelin oral solution) Gains U.S. Approval   Business Wire
Oct 27, 2020
08:00AM EDT  Elanco Releases Healthy Purpose(tm) 2030 Sustainability Commitments to Improve Health of Animals, People and Planet   Business Wire
Oct 13, 2020
03:00PM EDT  Elanco Recommends Shareholders Reject "Mini-Tender" Offer by TRC Capital Investment Corporation   Business Wire
Oct 11, 2020
11:08AM EDT  Cramer Shares His Thoughts On NCino, AT&T And More   Benzinga
Oct 9, 2020
08:30AM EDT  Elanco Confirms Date and Conference Call for Third Quarter 2020 Financial Results Announcement   Business Wire
Oct 7, 2020
01:50PM EDT  Elanco Animal Health Shares Quiet; Hearing Raymond James Sees Sale As An Unlikely Option 'Due To Company's Size'   Benzinga
10:49AM EDT  Elanco Animal Health 13D Filing From Sachem Head Capital Shows 5.9% Active Stake In Co.; BZ NOTE: Earlier Report Suggested Stake In Co.   Benzinga
Sep 30, 2020
11:01AM EDT  Shares of Elanco Animal Health Incorporated (ELAN) are up more than 4% Wednesday morning at $27.98 after the company announced job cuts to reduce costs.   RTTNews
07:48AM EDT  Elanco Animal Health Announces Business Restructuring -   RTTNews
07:35AM EDT  Elanco Animal Health Intends To Eliminate More Than 900 Positions Across Nearly 40 Countries   RTTNews
07:34AM EDT  Elanco Announces Restructuring Plans Including $100M Payment On Term Loan To Deleverage   Benzinga
07:30AM EDT  Elanco Announces Restructuring to Drive Synergies From Bayer Animal Health Acquisition   Business Wire
Sep 12, 2020
03:47PM EDT  Barron's Picks And Pans: Amazon, Crocs, GM, Microsoft And More   Benzinga
Sep 8, 2020
05:00PM EDT  Elanco to Participate in the Morgan Stanley 18th Annual Global Healthcare Conference   Business Wire
Aug 29, 2020
03:34PM EDT  Notable Insider Buys Last Week: Avis Budget, Axis Capital And More   Benzinga
Aug 20, 2020
10:57AM EDT  Why Elanco Animal Health's Stock Is Trading Higher Today   Benzinga
10:45AM EDT  Shares of Elanco Animal Health Incorporated (ELAN) are rising more than 6% Thursday morning at $27.29. It has traded in the range of $15.17- $32.66.   RTTNews
09:51AM EDT  Benzinga's Top Upgrades, Downgrades For August 20, 2020   Benzinga
06:35AM EDT  Morgan Stanley Upgrades Elanco Animal Health to Overweight, Announces $31 Price Target   Benzinga
Aug 13, 2020
05:14AM EDT  Credit Suisse Reinstates Neutral on Elanco Animal Health, Announces $27 Price Target   Benzinga
Aug 12, 2020
09:01AM EDT  Dr. Marijn Dekkers Joins AgBiome As a Strategic Advisor   PR Newswire
Aug 7, 2020
06:51AM EDT  Cramer Gives His Opinion On Datadog, Alcoa And More   Benzinga
Aug 4, 2020
03:22PM EDT  Why Elanco Animal's Stock Is Trading Higher Today   Benzinga
08:20AM EDT  Goldman Sachs Reinstates Buy on Elanco Animal Health, Announces $26.5 Price Target   Benzinga
Aug 3, 2020
06:36AM EDT  Merck Animal Health Completes Acquisition Of Worldwide Rights To VECOXAN From Elanco Animal Health   RTTNews
06:28AM EDT  Elanco Animal Health Inc. (ELAN) announced Monday that it has closed the acquisition of Bayer Animal Health. The transaction, valued at $6.89 billion, expands Elanco's scale and capabilities, positioning the company for the long term as a leader in the attractive, durable animal health industry.   RTTNews
06:08AM EDT  Elanco Animal Health Says Closes Acquisition Of Bayer Animal Health   RTTNews
06:00AM EDT  Elanco Closes Acquisition of Bayer Animal Health   Business Wire
Jul 31, 2020
09:52AM EDT  Elanco Animal Health Option Alert: Aug 21 $25 Calls at the Ask: 2500 @ $0.3 vs 7404 OI; Ref=$23.04   Benzinga
Jul 30, 2020
11:10AM EDT  Elanco Animal Health Inc. (ELAN) reported that its net loss for the second quarter of 2020 was $53.2 million or $0.13 per share, compared to net income of $35.9 million, or $0.10 per share, for the same period in 2019, reflecting the reduction of channel inventory and lower levels of demand resulting from the COVID-19 pandemic.   RTTNews
06:38AM EDT  Elanco Animal Health Q2 Loss/Shr $0.13 Vs EPS $0.10 Last Year   RTTNews
06:33AM EDT  Elanco Sees Q3 Core Revenue Excluding Strategic Exits $650M-$700M   Benzinga
06:31AM EDT  Elanco Animal Health Q2 Adj. EPS $0.09 Beats $0.06 Estimate, Sales $586.30M Miss $593.57M Estimate   Benzinga
06:31AM EDT  Elanco Animal Health Reports 2020 Second Quarter Results   Business Wire
04:06AM EDT  Earnings Scheduled For July 30, 2020   Benzinga
Jul 28, 2020
10:00AM EDT  Jason Kuhlemeier Joins AgBiome as VP of Marketing   PR Newswire
Jul 27, 2020
11:49AM EDT  Cleveland Research Downgrades Elanco Animal Health to Underperform, Announces $19 Price Target   Benzinga
Jul 21, 2020
10:00AM EDT  Gerald Coward Joins AgBiome as CFO   PR Newswire
Jul 20, 2020
11:17AM EDT  B of A Securities Maintains Buy on Elanco Animal Health, Raises Price Target to $28   Benzinga
11:00AM EDT  The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.   GlobeNewswire Inc
08:05AM EDT  Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of Elanco Animal Health Incorporated (Elanco or the Company) (NYSE: ELAN) to determine whether Elanco may have violated federal securities laws.   GlobeNewswire Inc
Jul 19, 2020
10:50PM EDT  & FOTI, LLC REMIND INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Deadline in Class Action Lawsuit Against Elanco Animal Health Incorporated - ELAN   PR Newswire
Jul 18, 2020
10:50PM EDT  ELANCO 48 HOUR DEADLINE ALERT: ClaimsFiler Reminds Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Elanco Animal Health Incorporated - ELAN   Business Wire
08:57AM EDT  LEGAL DEADLINE ALERTThe Law Firm of Barbuto &   GlobeNewswire Inc
Jul 17, 2020
10:50PM EDT  ELANCO 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Elanco Animal Health Incorporated - ELAN   Business Wire
01:40PM EDT  ELAN FINAL DEADLINE: ROSEN, A LEADING, LONGSTANDING, AND TOP   GlobeNewswire Inc
12:00PM EDT  ELAN Upcoming Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds   GlobeNewswire Inc
Jul 16, 2020
05:12PM EDT  Pomerantz LLP is investigating claims on behalf of investors of Elanco Animal Health Incorporated (Elanco or the Company) (NYSE:ELAN). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.   GlobeNewswire Inc
04:08PM EDT  PetIQ Received FTC Approval To Close Its $95 Million Acquisition Of The Capstar portfolio Of Products From Elanco Animal Health   Benzinga
04:05PM EDT  PetIQ, Inc. Receives FTC Approval to Close Acquisition of the   GlobeNewswire Inc
08:53AM EDT  Neogen Reports Will Purchase US Rights To Elanco's StandGuard Pour-On For Horn Fly, Lice Control In Beef Cattle, Related Assets, No Terms Disclosed   Benzinga
08:30AM EDT  First-of-its-Kind Study Shows 1 in 5 Dogs Visiting Dog Parks in Major U.S. Cities Tested Positive for Intestinal Parasites   Business Wire
Jul 15, 2020
10:50PM EDT  Kahn Swick & Foti, LLC (KSF) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending deadlines in the following securities class action lawsuits:   GlobeNewswire Inc
11:11AM EDT  Elanco Receives U.S. FTC Approval For Acquisition Of Bayer Animal Health; Deal On Track For Closing At Beginning Of Aug.   Benzinga
11:07AM EDT  Elanco Receives U.S. Federal Trade Commission Approval for Acquisition of Bayer Animal Health   Business Wire
Jul 14, 2020
12:00PM EDT  The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.   GlobeNewswire Inc
11:00AM EDT  ELAN Upcoming Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Elanco Animal Health Incorporated and Lead Plaintiff Deadline: July 20, 2020   Business Wire
Jul 13, 2020
11:45PM EDT  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of   PR Newswire
10:50PM EDT  ClaimsFiler, a FREE shareholder information service, reminds investors of pending deadlines in the following securities class action lawsuits:   GlobeNewswire Inc
Jul 11, 2020
11:48AM EDT  LEGAL DEADLINE ALERTThe Law Firm of Barbuto &   GlobeNewswire Inc


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC